Mitsubishi Tanabe recalls two million injectables
January 28, 2011Manufacturing and Production Mitsubishi, injectables, recall
Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …
Mike Paling receives outstanding contribution award
January 28, 2011Medical Communications Mike Paling, TBWA/Paling Walters, awards
Mike Paling, chief executive and chairman of TBWA\Paling Walters has received an award for Outstanding Contribution to Pharmaceutical Marketing for …
EMA road map to prioritise pharmacovigilance
January 28, 2011Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance
The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …
Mixed picture on postcode prescribing
January 28, 2011Sales and Marketing NHS reforms, PCTs, SHAs, postcode prescribing
There are high levels of variation between Strategic Health Authorities and Primacy Care Trusts in the uptake of new drugs, …
Decision on osteoporosis drug Protelos unchanged, says NICE
January 27, 2011Sales and Marketing NICE, Protelos, Servier, osteoporotic fractures, strontium ranelate
NICE has published updated final guidance on preventing osteoporotic fractures following a reconsideration of the use of Servier’s Protelos. The …
England isn’t the sick man of Europe
January 27, 2011Kings Fund, NHS, NHS reform, king's fund
A leading health economist has questioned claims by the health secretary Andrew Lansley that England’s health is lagging behind other …
Digital Pharma: Pfizer expands European Twitter use
January 27, 2011Medical Communications Digital Pharma blog, Pfizer, Twitter
Pfizer has expanded its use of Twitter with its French operations becoming the latest of its European subsidiaries to join …
Bertil Lindmark joins Almirall as R&D head
January 27, 2011Research and Development Almirall, Bertil Lindmark, appointment, research and development
Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Lilly Oncology chief resigns
January 27, 2011Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing
Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
Novartis posts strong growth but warns of tough year ahead
January 27, 2011Sales and Marketing 2010 pharma results, Novartis
Novartis has posted strong sales growth for the full year but its chief executive warns of ‘headwinds in 2011’ as …
Prime Minister uses online network to rally doctors around reforms
January 27, 2011Sales and Marketing Doctors.net.uk, GPs, commissioning, david cameron, docotrs, prime minister
Prime Minister David Cameron has made exclusive use of Doctors.net.uk, the UK’s largest network of medical professionals, to reinforce his …
NICE decides to back Abilify in schizophrenia
January 27, 2011Sales and Marketing Abilify, BMS, Bristol-Myers Squibb, NICE, Otsuka, aripiprazole, schizophrenia
NICE has changed its mind over Bristol-Myers Squibb’s and Otsuka Pharmaceuticals Abilify, deciding to recommend the drug as a schizophrenia …
Double Helix Consulting expands
January 26, 2011Sales and Marketing Clara Loveman, Double Helix, Dr Clive Whitcher, Dr Laurence Wild, appointment, sales and marketing
Double Helix Consulting has appointed three new executives to its growing global team – Clara Loveman, Dr Clive Whitcher and …
The Evolving Role of European Regulatory Agencies
January 26, 2011Research and Development Consultancy, regulatory affairs, regulatory agencies
The regulatory landscape can change in a very short period of time. Matthew Walker, Senior Regulatory Affairs Executive at TRAC …
Pharma-biotech partnerships: creative approaches to doing the deal
January 26, 2011Research and Development Susan Aldridge, biotech, biotech partnerships, pharma partnering
Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …
Sanofi buys into cancer antibody research
January 26, 2011Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research
Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …
J&J posts negative growth as pharma sales stall
January 26, 2011Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta
Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …
Dr Marie-Paule Richard joins AiCuris as CMO
January 26, 2011Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development
German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …
Eisai sepsis drug fails in phase III
January 26, 2011Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis
A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …
NHS competition will prevent postcode lottery, says Lansley
January 25, 2011NHS, NHS reforms, postcode prescribing
The government has pledged that value-based competition in the NHS will create “the very opposite of the postcode lottery”, following …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
